Scientific Program

AIRWAY VISTA 2022

COPD & Asthma : from Bench to Clinical Practice

  1. home
  2. Scientific Program
  3. Scientific Program

Airway Vista 2022 Program
- COPD & Asthma : from Bench to Clinical Practice -

March 27 (SUN) 2022

09:00-10:40 New Advances of Imaging in COPD and Asthma (English)
Joon Beom Seo,
Woo Jin Kim
09:00-09:25 Contributions of Hyperpolarized Gas MR Imaging to Our Understanding of COPD and Asthma
Warren Gefter
09:25-09:50 Small Airways Disease in COPD: Insights from Imaging Warren Gefter
09:50-10:15 Vascular Pruning on CT as a Marker of COPD-Related Pulmonary Vasculopathy
Andrew Synn
10:15-10:40 Air Pollution and Respiratory Health in a Changing Climate
Mary Rice
10:40-10:50 Visit Exhibitors

Online

On-site (Auditorium at Asan Institute of Life Sciences)
10:50-12:30 COPD Korean Session : COPD Management in COVID-19 Era in and after (Korean)
Kyeong-Cheol Shin 10:50-12:40 Collaboration session : Clinical unmet need and new solution with our partners - Diagnosis (Korean) Sang Min Lee
10:50-11:15 COPD management in COVID19 pandemic era
Hyun Jung Kim 10:50-11:00 Current state and limitation of quantification analysis on chest CT Sang Min Lee
11:15-11:40 New treatment of COPD beyond LAMA/LABA and ICS
Sun Hye Shin 11:00-11:25 Artificial Intelligence in Medicine: Pulmonary Disease Jihye Yun
11:40-12:05 COPD comorbidity: impact on pathogenesis and management
Ji-Ho Lee 11:25-11:50 Introduction of COPD Analysis Software using Artificial Intelligence Ji Won Lee
12:05-12:30 The importance of lifestyle modification in chronic respiratory diseases
Jieun Kang 11:50-12:15 User experience of chest CT analysis softwares Kum Ju Chae
12:30-12:40 Visit Exhibitors 12:15-12:40 Severe Alterations of CT-based Airway Structure and Lung Function in Subjects under Cement Dust Exposure Sanghun Choi
12:40-13:40 Luncheon Session
13:40-15:20 Asthma Korean Session: Advanced Strategy in Asthma Management (Korean)
You Sook Cho 13:40-15:30 Collaboration session : Clinical unmet need and new solution with our partners - Treatment (Korean) Jae Seung Lee
13:40-14:05 Precision medicine using current and upcoming biomarkers in asthma
Gyu Young Hur 13:40-13:50 Unmet Need from Clinical Side Jae Seung Lee
14:05-14:30 When should we consider the use of macrolides in asthma patients?
Han-Ki Park 13:50-14:15 Alveolar Organoids: Research and Applications Seokho Hong
14:30-14:55 Who can get the most benefit from triple therapy in Korean asthmatics?
Sun Young Yoon 14:15-14:40 Pulmonary Rehabilitation & Digital Therapeutics Hee Kwon
14:55-15:20 The potential therapeutic roles of biologics in patients with EGPA, ABPA and other eosinophilic disorders
Mi-Ae Kim 14:40-15:05 The human microbiome and the gut-lung axis Wilhelm Holzapfel
15:20-15:25 Closing 15:05-15:30 Distinctive lung interstitial macrophages suppress IL-23/TH17-mediated neutrophilic asthma via inhibition of NETosis Ji-Hwan Ryu
15:10-15:15 Closing